[123I]β-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients

European Neurology

Volumn 39, Issue 1, 1998, Pages 44-48

  Muller Th ^a   Farahati, J ^b,c   Kuhn, W ^a   Eising, E G ^b   Przuntek, H ^a   Reiners, C ^b,c   Coenen, H H ^b,d  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

123I CIT SPECT; Parkinson's disease; Presynaptic dopaminergic degeneration

Indexed keywords

COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; IODINE 123; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE;

ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; CASE CONTROL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTILLATION CAMERA; SCINTISCANNING;

ADULT; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031594660     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007896     Document Type: Article

References (21)

1. Uitti RJ, Calne DB: Pathogenesis of idiopathic parkinsonism. Eur Neurol 1993;33(suppl 1):6-23.
2. Agid Y: Parkinson's disease: Pathophysiology. Lancet 1991;337:1321-1324.
3. Innis RB: Single-photon emission tomography imaging of dopamine terminal innervation: A potential clinical tool in Parkinson's disease. Eur J Nucl Med 1994;21:1-5.
4. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995;38:589-598.
5. 123I]β-CIT SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996;46:231-237.
6. Melamed E: Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease. Adv Neurol 1990;53:61-66.
7. 123I]β-CIT SPECT. Parkinsonism Relat Disord 1995;1:47-51.
8. Kuikka JT, Bergstrom KA, Vanninen E, Laulumaa V, Hartikainen P, Lansimies E: Initial experience with single-photon emission tomography using iodine-123-labelled-β-carbomethoxy-3-β-(4-iodophenyl)tropane in human brain. Eur J Nucl Med 1993;20:783-786.
9. 123I]β-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 1993;94: 137-146.
10. Lehrner J, Brücke T, Kryspin Exner I, Asenbaum S, Podreka I: Impaired olfactory function in Parkinson's disease. Lancet 1995;345: 1054-1055.
11. Kuhn W, Heye N, Müller T, Kraus P, Klotz P, Friedrich B, Welter FL, Przuntek H: The Motor Performance Test Series in Parkinson's disease is influenced by depression. J Neural Transm 1996;103:349-354.
12. Pinter MM, Helscher RJ, Nasel CO, Riedl E, Schnaberth G: Quantification of motor deficit in Parkinson's disease with a motor performance test series. J Neural Transm Park Dis Dement Sect 1992;4:131-141.
13. Hautzinger M: The Beck Depression Inventory in clinical practice. Nervenarzt 1991;62:689-696.
14. Hughes AJ, Lees AJ, Stern GM: Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 1991; 41:1723-1725.
15. 123, 124I]β-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET. Nucl Med Biol 1995;8:977-984.
16. Angelberger P, Kvaternik H, Portner R, Hammerschmidt F: Radioactive isotopes in clinical medicine and research: in Bergmann H, Sinzinger H (eds): Advances in Pharmacological Sciences. Basel, Birkhäuser, 1995, pp 281-286.
17. van Hilten JJ, Middelkoop HA, Kuiper SI, Kramer CG, Roos RA: Where to record motor activity: An evaluation of commonly used sites of placement for activity monitors. Electroencephalogr Clin Neurophysiol 1993;89:359-362.
18. van Hilten JJ, Hoogland G, van der Velde EA, van Dijk JG, Kerkhof GA, Roos RA: Quantitative assessment of parkinsonian patients by continuous wrist activity monitoring. Clin Neuropharmacol 1993;16:36-45.
19. Paulus W, Jellinger K: The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50:743-755.
20. Hirsch EC, Mouatt A, Faucheux B: Dopamine, tremor, and Parkinson's disease. Lancet 1992; 340:125-126.
21. Kish SJ, Shannak K, Hornykiewicz O: Uneven pattern of dopamine loss in the striatum of patients with Parkinson's disease: Pathophysiological and clinical implications. N Engl J Med 1988;318:876-880.